<p>America pays less, on average, than any other major country for our generic drugs. But selling essential drugs at such low prices comes with hidden costs — from quality problems to frequent shortages.</p><br><p><em>This is the second episode of&nbsp;</em><a href="https://tradeoffs.org/racetothebottom/?utm_source=Tradeoffs&amp;utm_campaign=14192eec14-EMAIL_CAMPAIGN_2024_09_10_09_35&amp;utm_medium=email&amp;utm_term=0_-14192eec14-%5BLIST_EMAIL_ID%5D" rel="noopener noreferrer" target="_blank"><em>Race to the Bottom</em></a><em>, a three-part series by Tradeoffs on the problems plaguing the generic drugs we all rely on — and how we could fix them.</em></p><br><p>Guests:</p><p><a href="https://www.apotex.com/global/about-us/our-leadership" rel="noopener noreferrer" target="_blank">Christine Baeder</a>, MBA, President, Apotex USA</p><p><a href="https://www.angelsforchange.org/our-team" rel="noopener noreferrer" target="_blank">Laura Bray</a>, MBA, Founder, Angels for Change</p><p><a href="https://www.accessiblemeds.org/about/our-team/craig-burton" rel="noopener noreferrer" target="_blank">Craig Burton</a>, Senior Vice President of Policy and Strategic Alliances, Association for Accessible Medicines</p><p><a href="https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/iilun-murphy" rel="noopener noreferrer" target="_blank">Iilun Murphy</a>, MD, Director of the Office of Generic Drugs, FDA</p><p>Leslie Walker, Senior Reporter/Producer, Tradeoffs</p><p><a href="https://www.brookings.edu/people/marta-wosinska/" rel="noopener noreferrer" target="_blank">Marta Wosińska</a>, PhD, Senior Fellow, Brookings Institution</p><br><p><br></p><p>Learn more and read a full transcript on <a href="https://tradeoffs.org/2024/09/19/race-to-the-bottom-generic-drug-shortages" rel="noopener noreferrer" target="_blank">our website</a>.</p><br><p>Want more Tradeoffs? Sign up for our free <a href="https://tradeoffs.us3.list-manage.com/subscribe?u=6ab1fc39a0b1b15521551487c&amp;id=89c5edcb93&amp;utm_source=twitter-newsletter-signup&amp;utm_medium=twitter" rel="noopener noreferrer" target="_blank">weekly newsletter</a> featuring the latest health policy research and news.</p><br><p>Support this type of journalism today, <a href="https://tradeoffs.org/donate" rel="noopener noreferrer" target="_blank">with a gift</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

Tradeoffs

Tradeoffs

Race to the Bottom: Hard Bargain

JAN 8, 202629 MIN
Tradeoffs

Race to the Bottom: Hard Bargain

JAN 8, 202629 MIN

Description

<p>America pays less, on average, than any other major country for our generic drugs. But selling essential drugs at such low prices comes with hidden costs — from quality problems to frequent shortages.</p><br><p><em>This is the second episode of&nbsp;</em><a href="https://tradeoffs.org/racetothebottom/?utm_source=Tradeoffs&amp;utm_campaign=14192eec14-EMAIL_CAMPAIGN_2024_09_10_09_35&amp;utm_medium=email&amp;utm_term=0_-14192eec14-%5BLIST_EMAIL_ID%5D" rel="noopener noreferrer" target="_blank"><em>Race to the Bottom</em></a><em>, a three-part series by Tradeoffs on the problems plaguing the generic drugs we all rely on — and how we could fix them.</em></p><br><p>Guests:</p><p><a href="https://www.apotex.com/global/about-us/our-leadership" rel="noopener noreferrer" target="_blank">Christine Baeder</a>, MBA, President, Apotex USA</p><p><a href="https://www.angelsforchange.org/our-team" rel="noopener noreferrer" target="_blank">Laura Bray</a>, MBA, Founder, Angels for Change</p><p><a href="https://www.accessiblemeds.org/about/our-team/craig-burton" rel="noopener noreferrer" target="_blank">Craig Burton</a>, Senior Vice President of Policy and Strategic Alliances, Association for Accessible Medicines</p><p><a href="https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/iilun-murphy" rel="noopener noreferrer" target="_blank">Iilun Murphy</a>, MD, Director of the Office of Generic Drugs, FDA</p><p>Leslie Walker, Senior Reporter/Producer, Tradeoffs</p><p><a href="https://www.brookings.edu/people/marta-wosinska/" rel="noopener noreferrer" target="_blank">Marta Wosińska</a>, PhD, Senior Fellow, Brookings Institution</p><br><p><br></p><p>Learn more and read a full transcript on <a href="https://tradeoffs.org/2024/09/19/race-to-the-bottom-generic-drug-shortages" rel="noopener noreferrer" target="_blank">our website</a>.</p><br><p>Want more Tradeoffs? Sign up for our free <a href="https://tradeoffs.us3.list-manage.com/subscribe?u=6ab1fc39a0b1b15521551487c&amp;id=89c5edcb93&amp;utm_source=twitter-newsletter-signup&amp;utm_medium=twitter" rel="noopener noreferrer" target="_blank">weekly newsletter</a> featuring the latest health policy research and news.</p><br><p>Support this type of journalism today, <a href="https://tradeoffs.org/donate" rel="noopener noreferrer" target="_blank">with a gift</a>.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>